Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q1
WOS
Q2
Impact factor
2.6
SJR
1.077
CiteScore
3.8
Categories
Health Information Management
Health Policy
Health (social science)
Public Health, Environmental and Occupational Health
Areas
Health Professions
Medicine
Social Sciences
Years of issue
2017-2025
journal names
Health Equity
Top-3 citing journals

Health Equity
(113 citations)

Journal of racial and ethnic health disparities
(108 citations)
Top-3 organizations

University of California, San Francisco
(44 publications)

Harvard University
(28 publications)

Johns Hopkins University
(25 publications)

University of California, San Francisco
(37 publications)

Johns Hopkins University
(22 publications)

Harvard University
(21 publications)
Top-3 countries
Most cited in 5 years
Found
Publications found: 1113
Cutting-edge bioorthogonal chemistry: Innovations, practical applications, and emerging trends
Chetry A.B.
Bioorthogonal chemistry has emerged as a pivotal field in molecular science, offering transformative tools for applications in drug discovery, imaging, and molecular biology. This review provides a comprehensive analysis of recent advancements in bioorthogonal chemistry, emphasizing key innovations, practical applications, and future research directions. We explore state-of-the-art bioorthogonal reactions, including Staudinger ligation, strain-promoted azide-alkyne cycloaddition (SPAAC), and tetrazine ligation, detailing their mechanisms, advantages, and limitations. The review highlights significant innovations such as novel fluorogenic probes, improved catalysts, and enhanced reaction conditions that have expanded the utility and efficiency of these reactions. Practical applications are examined, showing how these advances have revolutionized fields like live-cell imaging, targeted drug delivery, and molecular labeling. Looking to the future, we discuss emerging trends and potential research avenues, including the integration of bioorthogonal chemistry with other advanced technologies and the development of new reaction methodologies. This review provides a detailed overview of the current state of bioorthogonal chemistry and outlines its future potential, serving as a valuable resource for researchers and practitioners in the field.
Synthesis and crystal structure determination of a new 1D polymer adduct of 1,2-di(pyridin-4-yl)ethane, based on B-N dative bonded eight-membered cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane
Bull O.S., Don-Lawson C.
A novel 1D polymer of 1,2-di(pyridin-4-yl)ethane (L1), connected via B-N dative-bonded adduct with an eight-membered cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane [Ph6B2Si2O4]·L1 was synthesized and characterized. The new compound [Ph6B2Si2O4]·L1 was prepared by the reaction of cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane and bis(pyridyl)ethane in a mixture of diethyl ether and petroleum ether solvents at reflux. The 1D polymer [Ph6B2Si2O4]·L1 was characterized by single-crystal X-ray diffraction, nuclear magnetic resonance, and FT-IR spectroscopy. The single crystal X-ray diffraction studies reveal that the aforementioned compound crystalized in the monoclinic crystal system with a centrosymmetric space group of P21/n (no. 14), a = 16.5378(4) Å, b = 12.6201(3) Å, c = 20.4904(5) Å, β = 96.689(2)°, V = 4247.43(18) Å3, Z = 4, T = 173.0 K, μ(MoKα) = 0.130 mm-1, Dcalc = 1.233 g/cm3, 14630 reflections measured (4.96° ≤ 2Θ ≤ 56.424°), 8424 unique (Rint = 0.0235, Rsigma = 0.0460) which were used in all calculations, the final R1 was 0.0455 (I > 2σ(I)) and wR2 was 0.1201 (all data). Furthermore, the compound exhibits various noncovalent interactions in the crystal packing, such as intermolecular and intramolecular, as well as hydrogen bonding. This study demonstrates the potential for making novel materials via the combination of cyclodiboradisiloxanes (Lewis acid) and nitrogen-containing ligands (Lewis bases).
Tetrachloro-(acetylacetonato)stannate(IV) and tri-iodocadmate(II) stabilized by a heptacyclic cation: Synthesis, characterization, and crystal structure
Ndiolene A., Diop T., Boye M.S., Diasse-Sarr A.
The tin (IV) and cadmium (II) complexes were synthesized in mixture, the ligand 4,4'-(ethane-1,2-diylbis(azanylylidene))bis(pent-2-en-2-ol), and the halide metal (SnCl2 or CdI2). Complex synthesis involves partial hydrolysis of the ligand followed by condensation cyclization. The new tin complex obtained crystallizes in the monoclinic space group P21/n with a = 8.5468(5) Å, b = 17.9907(9) Å, c = 12.7227(7) Å, β = 94.220(5) °, V = 1950.98(18) Å3 and Z = 4. The asymmetric unit consists of an anion tetrachloro-(acetylacetonato)stannate(IV) and a heptacyclic cation. The geometry of the complex is octahedral with cis coordination of the two oxygens of the acetylacetone. The cadmium complex crystallizes in the orthorhombic space group Pbca with a = 14.7395(9) Å, b = 8.5914(5) Å, c = 23.2825(13) Å, V = 2948.3(3) Å3, Z = 8. The geometry around cadmium is a deformed tetrahedron. The heptacyclic cation and the anionic complex are interconnected through hydrogen bonding interactions, specifically N–H···Cl or N–H···I, forming a network.
Synthesis, characterization, crystal structure and antioxidant activity of N-(3-chloropropionyl)-N'-(4-methoxyphenyl)thiourea
Abosadiya H.M.
In the present work, a new carbonoyl thiourea derivative, N-(3-chloropropionyl)-N'-(4-methoxyphenyl)thiourea, was synthesized by the reaction of 3-chloropropionyl isothiocyanate with 4-methoxyaniline in acetone solution. The newly synthesized compound was characterized by FT-IR, 1H NMR, and 13C NMR spectroscopic techniques. X-ray crystallographic studies indicate that the compound crystallized in the triclinic crystal system with space group P-1 and unit cell dimension are a = 10.2262(6) Å, b = 11.5007(7) Å, c = 12.6116(8) Å, α = 72.253(2)°, β = 66.348(2)°, γ = 88.099(2)°, Z = 4 and V = 1287.22 (14) Å3. Strong intramolecular O-H···N hydrogen bonds are present that form a six-member pseudo-ring S(6). In the crystal structure, the molecules are linked by N-H···O, N-H···S, and C-H···O intermolecular hydrogen bonding interactions formed infinite one-dimensional chains with an R22(8) and R22(12) rings motif of molecules. The antioxidant test using the DPPH method showed that the compound exhibits a good antioxidant activity of about 80%.
Redox behavior of aliphatic hydroxamic acid and its iron(III) complexes
Sow I.S., Vandeput M., Gelbcke M., Dufrasne F.
N-Hydroxydodecanamide (HA12) and its trihydroxamato-iron(III) complex (HA12Fe3) have been synthesized and characterized by various methods including structural determination by single crystal X-ray diffraction and cyclic voltammetry (CV). In order to complete our previous CV study on HA12 and its complexes, our aim was to investigate the variation in redox potential upon changes in concentration and pH. The redox couples previously observed with HA12 and HA12Fe3 at 100 µM shifts towards less positive values when the concentration or pH of the solution increases. These results indicate that oxidation is easier when concentrations are higher and in basic media. The slopes of -0.06 V/pH (in agreement with the theoretical data) and -0.077 V/pH (slightly higher than the theoretical slope) were observed for HA12 and HA12Fe3, respectively. This observation would explain the slower oxidation of HA12Fe3 than HA12.
Graphical Contents
Arslan H.
Graphical Contents
Methods for synthesizing hydroxamic acids and their metal complexes
Sow I.S.
In previously published works, the antibacterial, antifungal, antimycobacterial and anticancer activities of hydroxamic acids (HA) and their complexes were reported. Our recently published work shows that aliphatic HA with a number of carbon atoms equal to 12 (C12) and its Fe(II), Fe(III), Ni(II), Cu(II) and Zn(II) complexes are significantly active against bacteria (Staphylococcus aureus, Escherichia coli), fungal (Candida albicans) and mycobacteria (Mycobacterium smegmatis). Furthermore, the inhibitory activities against biofilms of Mycobacterium tuberculosis, Mycobacterium bovis BCG, Mycobacterium marinum and Pseudomonas aeruginosa were observed with a large number of HA and their complexes. Suberoylanilide HA and resminostat were approved to treat cutaneous T cell lymphoma and in clinical trials to treat advanced hepatocellular carcinoma, respectively. In view of the interesting biological properties of this family of chemical compounds, the synthesis of HA has been reported in numerous research articles in recent years but this is the second review article dedicated to their synthetic methods and the first review for their complexes. The aim of this review is to highlight optimal and rational methods for the synthesis of HA and their complexes. HA are obtained in near-quantitative yields from carboxylic acid, ethyl chloroformate, N-methylmorpholine and hydroxylamine. As for their complexes, the synthesis methods described are fairly similar and would all appear to be optimal. The main criteria are the number of equivalents of HA, the type of metal salt or solvent used and the reaction conditions.
Environmentally benign synthesis of substituted iodinated flavones as precursors for prenyl-/geranyl flavones from the corresponding chalcones
Khan S., Liza U.A., Banik D., Aman M.A., Happy K., Arjaya A.C., Hossain M.M.
Flavones have biological properties because of the existence of oxoheterocyclic ring moieties, and day by day create research interest areas because of their important biological activity. Iodine-substituted flavones were synthesized from the corresponding chalcones through an exhaustive iodination reaction. Generally, it is seen that halogenated flavones show better biological activity. Moreover, the introduction of iodine in the ring moiety facilitates the incorporation of highly active side chains, such as prenyl and geranyl groups through the formation of C-C bonds by numerous coupling reactions such as Sonogashira coupling. To achieve such target molecules, a planned chemical synthesis was conducted. For comparison, microwave irradiation (MWI) and conventional heating (CH) methods were used to synthesize a series of iodine-substituted flavone compounds with different substitutes (4a-d) from their corresponding chalcones (3a-d). Unfortunately, 3e chalcone (1-hydroxynapthalene substituted flavone) did not convert to 4e flavones. In the microwave method, a notable decrease in time required in the reaction and an increase in % yield of the reaction were remarked. Characterization and conformation of all synthesized compounds were done using ultraviolet, infrared, and nuclear magnetic resonance spectroscopy and elemental analysis.
Physicochemical characterization of siliceous sands of Seme-Podji/Benin: An application for the synthesis of silica particles
Glitho H.A., Osseni S.A., Bonou S.S., Plaisier J., Gigli L., Sagbo E., Chouti W.K.
In order to valorize locally available natural resources, the silica sand in the commune of Sèmè-Podji in Republic of Benin was characterized. The results obtained by particle size, chemical analysis, X-ray diffraction (XRD), and FT-IR analysis confirmed that these sands contain a high percentage of silicon dioxide, with a value approximately equal to 90 wt.%. Low Fe2O3 and Al2O3 content (<1 wt.%) and minor oxides such as K2O, Na2O, TiO2, and P2O5 (<0.6%) were also present. The size distributions of the particles show that the largest portion of the sand is found between 63 and 125 μm. This portion represents the one that contains the most silica. From this sand, silica particles were synthesized by the sol-gel method. The results obtained by X-ray diffraction (XRD), FT-IR analysis, and scanning electron microscopy (SEM) reveal the formation of pure amorphous silica.
Synthesis and in vitro evaluation of tetrazole containing 1,5-benzothiazepines as new anticancer, antitubercular, antibacterial, and antifungal agents
Suman A.K., Anu A., Singh B.
Heterocyclic scaffolds have attracted great attention of organic chemists and medicinal chemists, also because of their wide range of synthetic applicability and broad spectrum of biological profile. Therefore, in the present research work, a series of tetrazole containing 1,5-benzothiazepines have been synthesized for evaluation of their biological activities to determine the potential therapeutic profile of these compounds across various medicinal domains. Of the synthesized compounds, five compounds (6f, 8e, 8f, 8g, and 8h) have been screened for anticancer, antitubercular, antibacterial, and antifungal activities. After evaluation of these biological activities, it was found that these compounds possess very limited anticancer activity, moderate antibacterial and antifungal activity, and very strong antitubercular activity, which indicate their great pharmacological applications as subjects for future investigations of novel therapeutic agents for the treatment of tuberculosis.
Synthesis and characterization of a novel eight-membered cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane and 4,4ˈ-bipyridine, 1D adduct
Bull O.S., Don-Lawson C., Nweke-Maraizu U.
Simple adducts of cyclo-diboradisiloxanes (Lewis acid) and amines (Lewis base) have been reported in the literature. However, the method for the synthesis of an 8-membered cyclo-diboratetrasiloxane, as well as its adducts, was modified in this report to save cost and achieve new results. In the literature, the synthesis of cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane (Ph6B2Si2O4) (3) has been reported using diphenylsilanediol and phenylboronic acid and a Dean-Stark apparatus for the removal of water. However, in this study, molecular sieves were used for the facile removal of water, and the crude product recrystallized from diethyl ether and petroleum ether (3:1 ratio) to give compound 3. Compound 3 was reacted with 4,4’-bipyridine in a mixture of diethyl ether and petroleum ether solvents at reflux to give a 1D polymer [Ph6B2Si2O4]·L1 (4). Furthermore, compound 4 was characterized with various characterization methods such as single-crystal XRD, nuclear magnetic resonance, and FT-IR spectroscopy. The single crystal X-ray diffraction studies shows that the title compound crystalizes in the triclinic crystal system in the centrosymmetric space group P-1, a = 10.9372(4) Å, b = 18.4221(6) Å, c = 19.4697(6) Å, α = 70.533(3)°, β = 86.476(3)°, γ = 88.517(3)°, V = 3691.6(2) Å3, Z = 2, T = 173.0 K, μ(MoKα) = 0.122 mm-1, Dcalc = 1.204 g/cm3, 21463 reflections measured (5.196° ≤ 2Θ ≤ 56.45°), 14525 unique (Rint = 0.0185, Rsigma = 0.0483) which were used in all calculations, the final R1 was 0.0721 (I > 2σ(I)) and wR2 was 0.2143 (all data) with the 8-membered cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane (Ph6B2Si2O4) (3) configuration.
IgG neutralization potential of COVISHIELD™ vaccinated individual’s sera after booster vaccination: Longitudinal and prospective cohort study
Jagadeesan N., Kumar P., Gowda N.P., Karur K., Nanjappa M.C., Kumari P., Kumar H.T.
The novel SARS-CoV-2 (COVID-19) has caused widespread human turmoil by posing challenges concerning infection prevention, disease diagnosis, and treatment. Several approved vaccines including Sinovac (CoronaVac), COVISHIELD™ (Oxford/AstraZeneca formulation), Janssen (Johnson & Johnson), Sputnik V (Gamaleya), Covaxin (Bharat Biotech), Pfizer (BNT162b2), and others are being used to combat COVID-19. It is crucial to evaluate the kinetics of SARS-CoV-2 antibodies to predict the possibility of reinfection and the longevity of vaccination protection. There is a lack of data on longitudinal humoral antibody dynamics following two and three doses of the SARS-CoV-2 vaccination ChAdOx1-nCOV (COVISHIELDTM) in Indians. Thus, concerns about the efficacy of current vaccines have been raised by a sharp rise in coronavirus disease 2019 (Covid-19) cases caused by sub-variants of SARS-CoV-2 (Severe acute respiratory syndrome corona virus 2) in communities that have received massive vaccinations. The relative immunogenicity and safety of various COVID-19 immunizations administered as a third (booster) dose are not well known. We examined the reactogenicity and immunogenicity of the COVID-19 vaccine as a third dose after two doses of COVISHIELDTM to produce data to optimize the selection of booster vaccinations. After three doses of the COVID-19 vaccine, we evaluated the sera of COVISHIELDTM vaccine recipients for their ability to neutralize the virus. Primary immunization with two doses of COVISHIELDTM vaccine recipients provided significant protection against symptomatic disease caused by the SARS-CoV-2 variants. A COVISHIELDTM vaccine booster vaccine recipient substantially increased protection. The immunization findings showed a significant difference (p ≥ 0.001) between the COVID-19 naive vaccine (n = 438) and the sera of COVID-19-positive recovered subjects (n = 371) who received three doses of COVISHIELDTM. Our findings reveal that anti-RBD antibodies persist over time, which may reduce the probability of reinfection. A three-dose vaccination (n = 53) increases defense against variations by noticeably increasing cross-neutralizing antibody titers. Particularly against variants with antibody escape mutations.
Aqueous hydrotropes: An efficient and reusable catalyst for the synthesis of 3-carboxy-coumarin motifs at room temperature
Baviskar P.D., Kale A.D., Mahire V.N., Gosavi S.D., Dalal D.S., Mahulikar P.P.
The coumarin moiety plays an important role in the large number of natural products possessing different kinds of biological diversity. Coumarin carboxylic acids show a wide range of biological activities in the pharmaceutical and agricultural fields. Knoevenagel condensation is one of the important reaction pathways for synthesizing coumarin derivatives, and many methodologies have been developed to synthesize this class of compounds. A more environmentally friendly method of synthesizing 3-carboxy coumarins has been successfully carried out using 50% aqueous NaPTS hydrotropes at room temperature, along with various substituted 2-hydroxy benzaldehydes and Meldrum’s acid. This process involves Knoevenagel condensation followed by intramolecular cyclization, providing better product yields (78-95%).
Graphical Contents
Arslan H.
Graphical Contents
Single and mixed dithiocarbamato metal(III) complexes (Co, Rh, and Ir): Crystal and molecular structure description and interplay
Shotonwa I.O., Oduwole A.P., Agosu O.M., Yusuf A.F., Eze S.O.
This review focuses on the crystal and molecular structures of single and mixed dithiocarbamate ligands of cobalt, rhodium, and iridium in the +3 oxidation state. The complexities of their chelating and bridging modes come into play through modification of the substituents on the carbamate nitrogen atoms of the ligands and additional coordination of secondary phosphino-containing ligands, culminating in various applications such as biological, analytical, medicine, and catalysis. Other considerations include the geometrical coordination environments around the metal centres and their comparison with isostructural congeners. The distortions around the metal centres and their subsequent effects on the symmetries of bonds in the primary and secondary coordination spheres are discussed. The trans-effects of secondary P-ligands and their effects on geometrical alignment and structural stability have become valuable yardsticks in analyzing structural modifications and stabilities.
Top-100
Citing journals
20
40
60
80
100
120
140
|
|
International Journal of Environmental Research and Public Health
140 citations, 2.4%
|
|
Health Equity
113 citations, 1.94%
|
|
Journal of racial and ethnic health disparities
108 citations, 1.85%
|
|
BMC Public Health
78 citations, 1.34%
|
|
PLoS ONE
69 citations, 1.18%
|
|
Frontiers in Public Health
66 citations, 1.13%
|
|
JAMA network open
62 citations, 1.06%
|
|
Journal of General Internal Medicine
49 citations, 0.84%
|
|
Cureus
41 citations, 0.7%
|
|
Women's Health Issues
36 citations, 0.62%
|
|
Nutrients
34 citations, 0.58%
|
|
Social Science and Medicine
33 citations, 0.57%
|
|
BMJ Open
32 citations, 0.55%
|
|
BMC Medical Education
29 citations, 0.5%
|
|
American Journal of Public Health
27 citations, 0.46%
|
|
Preventive Medicine Reports
25 citations, 0.43%
|
|
International Journal for Equity in Health
24 citations, 0.41%
|
|
Journal of Midwifery and Women's Health
23 citations, 0.39%
|
|
Health Affairs
22 citations, 0.38%
|
|
Healthcare
22 citations, 0.38%
|
|
Obstetrics and Gynecology
22 citations, 0.38%
|
|
BMC Health Services Research
21 citations, 0.36%
|
|
Cancer
21 citations, 0.36%
|
|
Medical Care
21 citations, 0.36%
|
|
Journal of Women's Health
21 citations, 0.36%
|
|
JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing
20 citations, 0.34%
|
|
Maternal and Child Health Journal
19 citations, 0.33%
|
|
Journal of Public Health Management and Practice
19 citations, 0.33%
|
|
Milbank Quarterly
18 citations, 0.31%
|
|
Children
18 citations, 0.31%
|
|
Academic Medicine
17 citations, 0.29%
|
|
Journal of Community Health
17 citations, 0.29%
|
|
Health Services Research
17 citations, 0.29%
|
|
Contraception
17 citations, 0.29%
|
|
American Journal of Preventive Medicine
16 citations, 0.27%
|
|
Preventive Medicine
16 citations, 0.27%
|
|
Journal of Hunger and Environmental Nutrition
16 citations, 0.27%
|
|
Journal of Immigrant and Minority Health
16 citations, 0.27%
|
|
Vaccines
16 citations, 0.27%
|
|
American Journal of Obstetrics and Gynecology
15 citations, 0.26%
|
|
Annals of Surgical Oncology
15 citations, 0.26%
|
|
Journal of the National Medical Association
15 citations, 0.26%
|
|
Journal of Nutrition Education and Behavior
15 citations, 0.26%
|
|
BMJ Global Health
15 citations, 0.26%
|
|
Patient Education and Counseling
15 citations, 0.26%
|
|
Pediatrics
15 citations, 0.26%
|
|
Journal of Medical Internet Research
15 citations, 0.26%
|
|
American Journal of Surgery
15 citations, 0.26%
|
|
Nursing Outlook
15 citations, 0.26%
|
|
Journal of Rural Health
14 citations, 0.24%
|
|
Journal of the Academy of Nutrition and Dietetics
14 citations, 0.24%
|
|
Academic Pediatrics
14 citations, 0.24%
|
|
Journal of Surgical Research
14 citations, 0.24%
|
|
AIDS and Behavior
14 citations, 0.24%
|
|
Cancer Epidemiology Biomarkers and Prevention
13 citations, 0.22%
|
|
Public Health Nutrition
13 citations, 0.22%
|
|
Journal of Advanced Nursing
13 citations, 0.22%
|
|
Journal of the American Geriatrics Society
13 citations, 0.22%
|
|
Cancers
13 citations, 0.22%
|
|
Medical Science Educator
12 citations, 0.21%
|
|
Journal of Cancer Education
12 citations, 0.21%
|
|
Health Promotion Practice
12 citations, 0.21%
|
|
BMC Pregnancy and Childbirth
12 citations, 0.21%
|
|
Vaccine
12 citations, 0.21%
|
|
Scientific Reports
12 citations, 0.21%
|
|
Ethnicity and Health
12 citations, 0.21%
|
|
Preventing chronic disease
12 citations, 0.21%
|
|
Teaching and Learning in Medicine
12 citations, 0.21%
|
|
JMIR Formative Research
12 citations, 0.21%
|
|
Frontiers in Psychology
11 citations, 0.19%
|
|
Cancer Causes and Control
11 citations, 0.19%
|
|
Women's Health
11 citations, 0.19%
|
|
Journal of Surgical Oncology
11 citations, 0.19%
|
|
Journal of Pain and Symptom Management
11 citations, 0.19%
|
|
Qualitative Health Research
11 citations, 0.19%
|
|
Birth
11 citations, 0.19%
|
|
Behavioral Sciences
11 citations, 0.19%
|
|
Public Health Reports
11 citations, 0.19%
|
|
Circulation
11 citations, 0.19%
|
|
Journal of Palliative Medicine
10 citations, 0.17%
|
|
Journal of Community Psychology
10 citations, 0.17%
|
|
Journal of Genetic Counseling
10 citations, 0.17%
|
|
Seminars in Perinatology
10 citations, 0.17%
|
|
Heliyon
10 citations, 0.17%
|
|
Health and Place
10 citations, 0.17%
|
|
SSRN Electronic Journal
10 citations, 0.17%
|
|
JMIR Public Health and Surveillance
10 citations, 0.17%
|
|
Journal of Homosexuality
9 citations, 0.15%
|
|
SSM - Population Health
9 citations, 0.15%
|
|
Midwifery
9 citations, 0.15%
|
|
LGBT Health
9 citations, 0.15%
|
|
Journal of the American College of Radiology
9 citations, 0.15%
|
|
Gynecologic Oncology
9 citations, 0.15%
|
|
Journal of Affective Disorders
9 citations, 0.15%
|
|
Health Expectations
9 citations, 0.15%
|
|
Nicotine and Tobacco Research
8 citations, 0.14%
|
|
Sexuality Research and Social Policy
8 citations, 0.14%
|
|
Medical Education Online
8 citations, 0.14%
|
|
BMC Women's Health
8 citations, 0.14%
|
|
New England Journal of Medicine
8 citations, 0.14%
|
|
Show all (70 more) | |
20
40
60
80
100
120
140
|
Citing publishers
200
400
600
800
1000
1200
|
|
Elsevier
1152 citations, 19.78%
|
|
Springer Nature
1027 citations, 17.63%
|
|
Wiley
498 citations, 8.55%
|
|
Taylor & Francis
375 citations, 6.44%
|
|
MDPI
364 citations, 6.25%
|
|
SAGE
334 citations, 5.73%
|
|
Ovid Technologies (Wolters Kluwer Health)
308 citations, 5.29%
|
|
Mary Ann Liebert
210 citations, 3.61%
|
|
Frontiers Media S.A.
168 citations, 2.88%
|
|
Oxford University Press
110 citations, 1.89%
|
|
American Medical Association (AMA)
106 citations, 1.82%
|
|
JMIR Publications
99 citations, 1.7%
|
|
BMJ
94 citations, 1.61%
|
|
Public Library of Science (PLoS)
86 citations, 1.48%
|
|
Cold Spring Harbor Laboratory
68 citations, 1.17%
|
|
Cambridge University Press
45 citations, 0.77%
|
|
American Public Health Association
28 citations, 0.48%
|
|
American Society of Clinical Oncology (ASCO)
24 citations, 0.41%
|
|
IGI Global
24 citations, 0.41%
|
|
Health Affairs (Project Hope)
23 citations, 0.39%
|
|
Emerald
22 citations, 0.38%
|
|
American Academy of Pediatrics
22 citations, 0.38%
|
|
Georg Thieme Verlag KG
19 citations, 0.33%
|
|
American Association for Cancer Research (AACR)
18 citations, 0.31%
|
|
SciELO
17 citations, 0.29%
|
|
National Medical Association
15 citations, 0.26%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
15 citations, 0.26%
|
|
Centers for Disease Control and Prevention (CDC)
14 citations, 0.24%
|
|
Hindawi Limited
12 citations, 0.21%
|
|
American Society for Nutrition
11 citations, 0.19%
|
|
F1000 Research
11 citations, 0.19%
|
|
Research Square Platform LLC
11 citations, 0.19%
|
|
American Diabetes Association
10 citations, 0.17%
|
|
Massachusetts Medical Society
10 citations, 0.17%
|
|
Annual Reviews
10 citations, 0.17%
|
|
Baishideng Publishing Group
10 citations, 0.17%
|
|
SLACK
9 citations, 0.15%
|
|
AME Publishing Company
8 citations, 0.14%
|
|
American Psychiatric Association Publishing
8 citations, 0.14%
|
|
Walter de Gruyter
7 citations, 0.12%
|
|
Bentham Science Publishers Ltd.
7 citations, 0.12%
|
|
Association for Computing Machinery (ACM)
7 citations, 0.12%
|
|
American Speech Language Hearing Association
5 citations, 0.09%
|
|
Radiological Society of North America (RSNA)
5 citations, 0.09%
|
|
Association of Military Surgeons of the US
5 citations, 0.09%
|
|
Ubiquity Press
5 citations, 0.09%
|
|
Scientific Research Publishing
5 citations, 0.09%
|
|
AOSIS
5 citations, 0.09%
|
|
The Endocrine Society
4 citations, 0.07%
|
|
American Thoracic Society
4 citations, 0.07%
|
|
CSIRO Publishing
4 citations, 0.07%
|
|
Social Science Electronic Publishing
4 citations, 0.07%
|
|
University of Toronto Press Inc. (UTPress)
4 citations, 0.07%
|
|
Centers for Disease Control MMWR Office
4 citations, 0.07%
|
|
IOS Press
3 citations, 0.05%
|
|
University of California Press
3 citations, 0.05%
|
|
American Society for Microbiology
3 citations, 0.05%
|
|
American Physiological Society
3 citations, 0.05%
|
|
Duke University Press
3 citations, 0.05%
|
|
Springer Publishing Company
3 citations, 0.05%
|
|
American College of Physicians
3 citations, 0.05%
|
|
Society for Translational Oncology
3 citations, 0.05%
|
|
Moffitt Cancer Center
3 citations, 0.05%
|
|
Canadian Science Publishing
3 citations, 0.05%
|
|
PAGEPress Publications
3 citations, 0.05%
|
|
Environmental Health Perspectives
3 citations, 0.05%
|
|
Guilford Publications
3 citations, 0.05%
|
|
International Global Health Society
3 citations, 0.05%
|
|
Journal of Graduate Medical Education
3 citations, 0.05%
|
|
EDP Sciences
2 citations, 0.03%
|
|
Jones and Barlett Publishers
2 citations, 0.03%
|
|
PeerJ
2 citations, 0.03%
|
|
Spandidos Publications
2 citations, 0.03%
|
|
American Association of Colleges of Pharmacy
2 citations, 0.03%
|
|
Oncology Nursing Society
2 citations, 0.03%
|
|
Universidade Federal de Santa Catarina
2 citations, 0.03%
|
|
IOP Publishing
2 citations, 0.03%
|
|
American Society of Hematology
2 citations, 0.03%
|
|
Vilnius University Press
2 citations, 0.03%
|
|
Medknow
2 citations, 0.03%
|
|
S. Karger AG
2 citations, 0.03%
|
|
Publishing House ABV Press
2 citations, 0.03%
|
|
American Society of Civil Engineers (ASCE)
2 citations, 0.03%
|
|
Academy of Managed Care Pharmacy
2 citations, 0.03%
|
|
Consortium Erudit
2 citations, 0.03%
|
|
National Academy of Medicine
2 citations, 0.03%
|
|
IntechOpen
2 citations, 0.03%
|
|
South Florida Publishing LLC
2 citations, 0.03%
|
|
Society of Hospital Medicine
2 citations, 0.03%
|
|
Southern Medical Association
2 citations, 0.03%
|
|
American Marketing Association
1 citation, 0.02%
|
|
Begell House
1 citation, 0.02%
|
|
Brill
1 citation, 0.02%
|
|
Royal Society of Chemistry (RSC)
1 citation, 0.02%
|
|
King Saud University
1 citation, 0.02%
|
|
The Royal Society
1 citation, 0.02%
|
|
University of Chicago Press
1 citation, 0.02%
|
|
1 citation, 0.02%
|
|
Max-Planck Institute for Demographic Research/Max-Planck-institut fur Demografische Forschung
1 citation, 0.02%
|
|
Associacao Brasileira de Enfermagem
1 citation, 0.02%
|
|
Show all (70 more) | |
200
400
600
800
1000
1200
|
Publishing organizations
5
10
15
20
25
30
35
40
45
|
|
University of California, San Francisco
44 publications, 6.88%
|
|
Harvard University
28 publications, 4.38%
|
|
Johns Hopkins University
25 publications, 3.91%
|
|
New York University
25 publications, 3.91%
|
|
University of California, Los Angeles
21 publications, 3.28%
|
|
University of Illinois at Chicago
19 publications, 2.97%
|
|
University of Washington
19 publications, 2.97%
|
|
University of Michigan
19 publications, 2.97%
|
|
University of North Carolina at Chapel Hill
19 publications, 2.97%
|
|
Duke University
17 publications, 2.66%
|
|
University of Pennsylvania
17 publications, 2.66%
|
|
Stanford University
16 publications, 2.5%
|
|
University of Alabama at Birmingham
16 publications, 2.5%
|
|
Columbia University
15 publications, 2.34%
|
|
Massachusetts General Hospital
15 publications, 2.34%
|
|
Boston University
14 publications, 2.19%
|
|
Washington University in St. Louis
14 publications, 2.19%
|
|
Northwestern University
14 publications, 2.19%
|
|
University of Minnesota
14 publications, 2.19%
|
|
Drexel University
13 publications, 2.03%
|
|
Yale University
13 publications, 2.03%
|
|
National Institute on Minority Health and Health Disparities
13 publications, 2.03%
|
|
Brown University
12 publications, 1.88%
|
|
University of Southern California
11 publications, 1.72%
|
|
Brigham and Women's Hospital
11 publications, 1.72%
|
|
University of Colorado Anschutz Medical Campus
11 publications, 1.72%
|
|
Oregon Health & Science University
10 publications, 1.56%
|
|
University of California, Berkeley
10 publications, 1.56%
|
|
Icahn School of Medicine at Mount Sinai
10 publications, 1.56%
|
|
Michigan State University
9 publications, 1.41%
|
|
Cornell University
9 publications, 1.41%
|
|
University of Miami
8 publications, 1.25%
|
|
University of Utah
8 publications, 1.25%
|
|
University of Connecticut
8 publications, 1.25%
|
|
National Cancer Institute
7 publications, 1.09%
|
|
Rutgers, The State University of New Jersey
6 publications, 0.94%
|
|
Ohio State University
6 publications, 0.94%
|
|
University of California, San Diego
6 publications, 0.94%
|
|
University of Wisconsin–Madison
6 publications, 0.94%
|
|
Emory University
6 publications, 0.94%
|
|
Temple University
6 publications, 0.94%
|
|
University of Texas Health Science Center at Houston
6 publications, 0.94%
|
|
George Washington University
5 publications, 0.78%
|
|
Washington State University
5 publications, 0.78%
|
|
Clemson University
5 publications, 0.78%
|
|
Boston Children's Hospital
5 publications, 0.78%
|
|
University of Texas at Austin
5 publications, 0.78%
|
|
Albert Einstein College of Medicine
5 publications, 0.78%
|
|
Medical College of Wisconsin
5 publications, 0.78%
|
|
University of Maryland, College Park
5 publications, 0.78%
|
|
National Heart, Lung, and Blood Institute
5 publications, 0.78%
|
|
University of Cincinnati
5 publications, 0.78%
|
|
University of Texas Medical Branch
5 publications, 0.78%
|
|
University of Nebraska Medical Center
5 publications, 0.78%
|
|
University of Houston
5 publications, 0.78%
|
|
Portland State University
5 publications, 0.78%
|
|
Georgetown University
4 publications, 0.63%
|
|
American University
4 publications, 0.63%
|
|
Arizona State University
4 publications, 0.63%
|
|
Duke University Hospital
4 publications, 0.63%
|
|
Tufts University
4 publications, 0.63%
|
|
University of California, Davis
4 publications, 0.63%
|
|
University of California, Irvine
4 publications, 0.63%
|
|
University of California, Santa Barbara
4 publications, 0.63%
|
|
University of Illinois Urbana-Champaign
4 publications, 0.63%
|
|
University of British Columbia
4 publications, 0.63%
|
|
Indiana University–Purdue University Indianapolis
4 publications, 0.63%
|
|
Virginia Commonwealth University
4 publications, 0.63%
|
|
University of Texas Southwestern Medical Center
4 publications, 0.63%
|
|
University of Maryland, Baltimore
4 publications, 0.63%
|
|
Fox Chase Cancer Center
4 publications, 0.63%
|
|
University of Toronto
4 publications, 0.63%
|
|
Florida International University
4 publications, 0.63%
|
|
University of Florida
4 publications, 0.63%
|
|
UNC Lineberger Comprehensive Cancer Center
4 publications, 0.63%
|
|
Miami University
4 publications, 0.63%
|
|
Cincinnati Children's Hospital Medical Center
4 publications, 0.63%
|
|
University of Rochester
4 publications, 0.63%
|
|
City of Hope National Medical Center
4 publications, 0.63%
|
|
Indiana University School of Medicine
4 publications, 0.63%
|
|
University of North Texas Health Science Center
4 publications, 0.63%
|
|
National Institutes of Health Clinical Center
4 publications, 0.63%
|
|
San Jose State University
4 publications, 0.63%
|
|
King Saud University
3 publications, 0.47%
|
|
Pennsylvania State University
3 publications, 0.47%
|
|
Georgetown University Medical Center
3 publications, 0.47%
|
|
George Mason University
3 publications, 0.47%
|
|
Spaulding Rehabilitation Hospital
3 publications, 0.47%
|
|
Dana-Farber Cancer Institute
3 publications, 0.47%
|
|
Olive View–UCLA Medical Center
3 publications, 0.47%
|
|
UC Davis Comprehensive Cancer Center
3 publications, 0.47%
|
|
San Diego State University
3 publications, 0.47%
|
|
Loyola University Chicago
3 publications, 0.47%
|
|
University of Chicago
3 publications, 0.47%
|
|
Vanderbilt University
3 publications, 0.47%
|
|
University of Michigan–Flint
3 publications, 0.47%
|
|
Boston College
3 publications, 0.47%
|
|
Baylor College of Medicine
3 publications, 0.47%
|
|
Food and Drug Administration
3 publications, 0.47%
|
|
Thomas Jefferson University
3 publications, 0.47%
|
|
Show all (70 more) | |
5
10
15
20
25
30
35
40
45
|
Publishing organizations in 5 years
5
10
15
20
25
30
35
40
|
|
University of California, San Francisco
37 publications, 7.74%
|
|
Johns Hopkins University
22 publications, 4.6%
|
|
Harvard University
21 publications, 4.39%
|
|
New York University
21 publications, 4.39%
|
|
Duke University
16 publications, 3.35%
|
|
University of Washington
16 publications, 3.35%
|
|
University of North Carolina at Chapel Hill
15 publications, 3.14%
|
|
University of Illinois at Chicago
13 publications, 2.72%
|
|
University of California, Los Angeles
13 publications, 2.72%
|
|
University of Alabama at Birmingham
13 publications, 2.72%
|
|
Stanford University
12 publications, 2.51%
|
|
University of Pennsylvania
12 publications, 2.51%
|
|
Columbia University
11 publications, 2.3%
|
|
Northwestern University
11 publications, 2.3%
|
|
University of Michigan
11 publications, 2.3%
|
|
National Institute on Minority Health and Health Disparities
11 publications, 2.3%
|
|
Yale University
10 publications, 2.09%
|
|
Boston University
10 publications, 2.09%
|
|
University of California, Berkeley
10 publications, 2.09%
|
|
Massachusetts General Hospital
10 publications, 2.09%
|
|
Drexel University
9 publications, 1.88%
|
|
Oregon Health & Science University
9 publications, 1.88%
|
|
Brigham and Women's Hospital
9 publications, 1.88%
|
|
University of Colorado Anschutz Medical Campus
9 publications, 1.88%
|
|
University of Southern California
8 publications, 1.67%
|
|
University of Minnesota
8 publications, 1.67%
|
|
University of Miami
8 publications, 1.67%
|
|
Michigan State University
7 publications, 1.46%
|
|
Cornell University
7 publications, 1.46%
|
|
Washington University in St. Louis
7 publications, 1.46%
|
|
Brown University
7 publications, 1.46%
|
|
Icahn School of Medicine at Mount Sinai
6 publications, 1.26%
|
|
University of Connecticut
6 publications, 1.26%
|
|
University of California, San Diego
5 publications, 1.05%
|
|
University of Wisconsin–Madison
5 publications, 1.05%
|
|
Emory University
5 publications, 1.05%
|
|
Temple University
5 publications, 1.05%
|
|
National Heart, Lung, and Blood Institute
5 publications, 1.05%
|
|
University of Cincinnati
5 publications, 1.05%
|
|
University of Utah
5 publications, 1.05%
|
|
Georgetown University
4 publications, 0.84%
|
|
Washington State University
4 publications, 0.84%
|
|
Arizona State University
4 publications, 0.84%
|
|
Duke University Hospital
4 publications, 0.84%
|
|
Boston Children's Hospital
4 publications, 0.84%
|
|
University of California, Davis
4 publications, 0.84%
|
|
University of Texas at Austin
4 publications, 0.84%
|
|
Albert Einstein College of Medicine
4 publications, 0.84%
|
|
University of Texas Southwestern Medical Center
4 publications, 0.84%
|
|
Medical College of Wisconsin
4 publications, 0.84%
|
|
University of Maryland, College Park
4 publications, 0.84%
|
|
UNC Lineberger Comprehensive Cancer Center
4 publications, 0.84%
|
|
Cincinnati Children's Hospital Medical Center
4 publications, 0.84%
|
|
University of Rochester
4 publications, 0.84%
|
|
City of Hope National Medical Center
4 publications, 0.84%
|
|
University of North Texas Health Science Center
4 publications, 0.84%
|
|
University of Houston
4 publications, 0.84%
|
|
National Cancer Institute
4 publications, 0.84%
|
|
Portland State University
4 publications, 0.84%
|
|
San Jose State University
4 publications, 0.84%
|
|
King Saud University
3 publications, 0.63%
|
|
Pennsylvania State University
3 publications, 0.63%
|
|
Clemson University
3 publications, 0.63%
|
|
Ohio State University
3 publications, 0.63%
|
|
Tufts University
3 publications, 0.63%
|
|
UC Davis Comprehensive Cancer Center
3 publications, 0.63%
|
|
San Diego State University
3 publications, 0.63%
|
|
Loyola University Chicago
3 publications, 0.63%
|
|
University of Illinois Urbana-Champaign
3 publications, 0.63%
|
|
University of Michigan–Flint
3 publications, 0.63%
|
|
Baylor College of Medicine
3 publications, 0.63%
|
|
University of British Columbia
3 publications, 0.63%
|
|
Indiana University–Purdue University Indianapolis
3 publications, 0.63%
|
|
University of Maryland, Baltimore
3 publications, 0.63%
|
|
East Carolina University
3 publications, 0.63%
|
|
Fox Chase Cancer Center
3 publications, 0.63%
|
|
Mayo Clinic
3 publications, 0.63%
|
|
University of Toronto
3 publications, 0.63%
|
|
University of Calgary
3 publications, 0.63%
|
|
University of Florida
3 publications, 0.63%
|
|
University of Kentucky
3 publications, 0.63%
|
|
Indiana University School of Medicine
3 publications, 0.63%
|
|
University of Texas Health Science Center at Houston
3 publications, 0.63%
|
|
University of Nebraska Medical Center
3 publications, 0.63%
|
|
Florida State University
2 publications, 0.42%
|
|
George Washington University
2 publications, 0.42%
|
|
Airlangga university
2 publications, 0.42%
|
|
Mahidol University
2 publications, 0.42%
|
|
American University
2 publications, 0.42%
|
|
North Carolina State University
2 publications, 0.42%
|
|
University of Missouri–Kansas City
2 publications, 0.42%
|
|
Rutgers, The State University of New Jersey
2 publications, 0.42%
|
|
George Mason University
2 publications, 0.42%
|
|
Case Western Reserve University
2 publications, 0.42%
|
|
Spaulding Rehabilitation Hospital
2 publications, 0.42%
|
|
Dana-Farber/Harvard Cancer Center
2 publications, 0.42%
|
|
Dana-Farber Cancer Institute
2 publications, 0.42%
|
|
San Francisco State University
2 publications, 0.42%
|
|
University at Buffalo, State University of New York
2 publications, 0.42%
|
|
University of California, Irvine
2 publications, 0.42%
|
|
Show all (70 more) | |
5
10
15
20
25
30
35
40
|
Publishing countries
100
200
300
400
500
600
|
|
USA
|
USA, 588, 91.88%
USA
588 publications, 91.88%
|
Canada
|
Canada, 19, 2.97%
Canada
19 publications, 2.97%
|
United Kingdom
|
United Kingdom, 5, 0.78%
United Kingdom
5 publications, 0.78%
|
Australia
|
Australia, 4, 0.63%
Australia
4 publications, 0.63%
|
Brazil
|
Brazil, 3, 0.47%
Brazil
3 publications, 0.47%
|
Indonesia
|
Indonesia, 3, 0.47%
Indonesia
3 publications, 0.47%
|
Saudi Arabia
|
Saudi Arabia, 3, 0.47%
Saudi Arabia
3 publications, 0.47%
|
Thailand
|
Thailand, 3, 0.47%
Thailand
3 publications, 0.47%
|
France
|
France, 2, 0.31%
France
2 publications, 0.31%
|
China
|
China, 2, 0.31%
China
2 publications, 0.31%
|
Spain
|
Spain, 2, 0.31%
Spain
2 publications, 0.31%
|
Italy
|
Italy, 2, 0.31%
Italy
2 publications, 0.31%
|
Mexico
|
Mexico, 2, 0.31%
Mexico
2 publications, 0.31%
|
Puerto Rico
|
Puerto Rico, 2, 0.31%
Puerto Rico
2 publications, 0.31%
|
Switzerland
|
Switzerland, 2, 0.31%
Switzerland
2 publications, 0.31%
|
Germany
|
Germany, 1, 0.16%
Germany
1 publication, 0.16%
|
Belgium
|
Belgium, 1, 0.16%
Belgium
1 publication, 0.16%
|
Vatican
|
Vatican, 1, 0.16%
Vatican
1 publication, 0.16%
|
Ghana
|
Ghana, 1, 0.16%
Ghana
1 publication, 0.16%
|
India
|
India, 1, 0.16%
India
1 publication, 0.16%
|
Lebanon
|
Lebanon, 1, 0.16%
Lebanon
1 publication, 0.16%
|
Malaysia
|
Malaysia, 1, 0.16%
Malaysia
1 publication, 0.16%
|
Nepal
|
Nepal, 1, 0.16%
Nepal
1 publication, 0.16%
|
Netherlands
|
Netherlands, 1, 0.16%
Netherlands
1 publication, 0.16%
|
New Zealand
|
New Zealand, 1, 0.16%
New Zealand
1 publication, 0.16%
|
Republic of Korea
|
Republic of Korea, 1, 0.16%
Republic of Korea
1 publication, 0.16%
|
South Africa
|
South Africa, 1, 0.16%
South Africa
1 publication, 0.16%
|
Jamaica
|
Jamaica, 1, 0.16%
Jamaica
1 publication, 0.16%
|
Japan
|
Japan, 1, 0.16%
Japan
1 publication, 0.16%
|
100
200
300
400
500
600
|
Publishing countries in 5 years
50
100
150
200
250
300
350
400
450
|
|
USA
|
USA, 436, 91.21%
USA
436 publications, 91.21%
|
Canada
|
Canada, 14, 2.93%
Canada
14 publications, 2.93%
|
United Kingdom
|
United Kingdom, 4, 0.84%
United Kingdom
4 publications, 0.84%
|
Australia
|
Australia, 3, 0.63%
Australia
3 publications, 0.63%
|
Brazil
|
Brazil, 3, 0.63%
Brazil
3 publications, 0.63%
|
Indonesia
|
Indonesia, 3, 0.63%
Indonesia
3 publications, 0.63%
|
Saudi Arabia
|
Saudi Arabia, 3, 0.63%
Saudi Arabia
3 publications, 0.63%
|
Thailand
|
Thailand, 3, 0.63%
Thailand
3 publications, 0.63%
|
France
|
France, 2, 0.42%
France
2 publications, 0.42%
|
China
|
China, 2, 0.42%
China
2 publications, 0.42%
|
Spain
|
Spain, 2, 0.42%
Spain
2 publications, 0.42%
|
Switzerland
|
Switzerland, 2, 0.42%
Switzerland
2 publications, 0.42%
|
Germany
|
Germany, 1, 0.21%
Germany
1 publication, 0.21%
|
Belgium
|
Belgium, 1, 0.21%
Belgium
1 publication, 0.21%
|
Vatican
|
Vatican, 1, 0.21%
Vatican
1 publication, 0.21%
|
Ghana
|
Ghana, 1, 0.21%
Ghana
1 publication, 0.21%
|
Italy
|
Italy, 1, 0.21%
Italy
1 publication, 0.21%
|
Lebanon
|
Lebanon, 1, 0.21%
Lebanon
1 publication, 0.21%
|
Malaysia
|
Malaysia, 1, 0.21%
Malaysia
1 publication, 0.21%
|
Mexico
|
Mexico, 1, 0.21%
Mexico
1 publication, 0.21%
|
Nepal
|
Nepal, 1, 0.21%
Nepal
1 publication, 0.21%
|
Netherlands
|
Netherlands, 1, 0.21%
Netherlands
1 publication, 0.21%
|
Puerto Rico
|
Puerto Rico, 1, 0.21%
Puerto Rico
1 publication, 0.21%
|
Republic of Korea
|
Republic of Korea, 1, 0.21%
Republic of Korea
1 publication, 0.21%
|
South Africa
|
South Africa, 1, 0.21%
South Africa
1 publication, 0.21%
|
Jamaica
|
Jamaica, 1, 0.21%
Jamaica
1 publication, 0.21%
|
Japan
|
Japan, 1, 0.21%
Japan
1 publication, 0.21%
|
50
100
150
200
250
300
350
400
450
|
1 profile journal article
Lins-Kusterer Liliane
97 publications,
1 171 citations
h-index: 12